Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results

Provided By GlobeNewswire

Last update: Aug 8, 2024

SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today provided a business update and reported second quarter 2024 financial results.